A Study to Test How Healthy Women Tolerate Different Doses of BI 1819479

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main objectives of this trial are to investigate safety, tolerability and pharmacokinetics (PK) of BI 1819479 in healthy female subjects of non-childbearing potential.
Epistemonikos ID: 135b1c5d4789426bc28ecfba47ac52a171c4bf53
First added on: May 13, 2024